Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice

Hulin, Cyrille; de la Rubia, Javier; Α. Dimopoulos, Meletios; Terpos, Evangelos; Katodritou, Eirini; Hungria, Vânia; De Samblanx, Hadewijch; Stoppa, Anne‐Marie; Aagesen, Jesper; Sargın, Deniz; Sioni, Anastasia; Belch, Andrew; Diels, Joris; A. Olie, Robert; Robinson, Don; Potamianou, Anna; van de Velde, Helgi; Delforge, Michel

doi:10.1002/hsr2.104

Public

Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice

Published in Health Science Reports • Dec 7, 2018

Authors:

Cyrille Hulin

Javier de la Rubia

Meletios Α. Dimopoulos

Abstract

AIMS: OBservational Study (eVOBS) study assessed bortezomib-based therapies for patients with MM in everyday practice. Here, we report on those patients receiving retreatment with bortezomib. METHODS: Consenting adults scheduled to receive bortezomib for MM were enrolled at 162 sites across Europe, ...

Subject

Bortezomib

Medicine

Multiple myeloma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!